China Medical System Holdings Limited

CMSs 867.HK/8A8.SG Self-developed Innovative INHBE-Targeting siRNA Drug CMS-D008 Presents Its Preclinical Results at the ADA Scientific Sessions

SHENZHEN, CHINA, June 8, 2026 - (ACN Newswire) - China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that the preclinical results of its self-developed innovative INHBE-targeting small nucleic acid drug CMS-D008 injection ("CMS-D008"), ha ...

09.06.2026 | Vermischtes